Business
Trading Update
Trading Update.
About this update from Trellus Health Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n \n \n \n \n Trellus Health plc\n \n \n \n (\"Trellus Health\" or the \"Company\")\n \n \n \n \n \n \n Trading Update\n \n \n \n \n \n \n \n LONDON, U.K. AND NEW YORK, U.S. (6 March\n \n \n 2023).\n \n Trellus Health plc (AIM: TRLS), which is commercializing a scientifically validated, personalized resilience-driven self-management solution for chronic health conditions at their intersection with mental health, provides an update on progress, strategy, financial position and current trading.\n \n \n \n \n \n Progress and strategy\n \n \n \n \n \n \n \n \n At 31 December 2022, there were over 100 users of\n the\n Trellus Resilience Training and Self-Management Program for Inflammatory Bowel Disease (the \"Trellus IBD program\"), coming from a range of sources including Athletes vs Crohn's and Colitis, Connecting to Cure, and other select IBD centers throughout the US. Since the start of 2023, the number of sign-ups have grown, due in part to the two contracts signed with the Mount Sinai Health System (\"Mount Sinai\") in October 2022 becoming active this year.\n \n \n \n \n Feedback received since launching the revised delivery method for the Trellus programs in July 2022 has been highly positive. Since beginning the Trellus IBD Program:\n \n \n \n \n \n · 83% of members reported an increase in their self-confidence in how to manage their condition;\n \n · 92% of members reported an increase in their self-management skills and behavior change; and\n \n · 60% reported an improvement in their emotional and mental wellbeing.\n \n \n \n \n The Company is continuing to evolve and execute its strategy, including the targeting of further small-scale pilot and demonstration projects in both IBD and the recently launched irritable bowel syndrome (IBS) offering. Trellus Health's objective here is to continue generating further data to validate the use and outcomes of the Trellus Method.\n \n \n \n \n \n This real-world data is being utilised by the Company to support B2B2C engagement in larger project opportunities,\n including employers, regional and national health plans\n to enable the wider rollout of its solution. This activity\n builds upon recently announced agreements with Mount Sinai and the New York Medicaid Health Plan.\n \n \n \n \n \n \n Financi...